Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tony S K Mok
John Crowley

Showing results (1-10 of 301) with videos related to

Pageof 31
Sort By:
Nature Reviews. Clinical Oncology|August 25, 2011
Personalized medicine in lung cancer: what we need to knowTony S K Mok
Cancer|August 7, 2009
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigmTony S K Mok, Suresh S Ramalingam
Nature Reviews. Clinical Oncology|May 21, 2014
Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLCHerbert H Loong, Tony S K Mok
Thoracic Surgery Clinics|September 24, 2004
Methodology for quality-of-life assessment: a critical appraisalBenny Chung-Ying Zee, Tony S K Mok
Seminars in Oncology|February 26, 2014
Targeting epidermal growth factor receptor in the management of lung cancerTony S K Mok, Kirsty Lee, Linda Leung
Therapeutic Advances in Medical Oncology|July 4, 2012
Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancerLinda Leung, Tony S K Mok, Herbert Loong
Drugs|June 21, 2012
Clinical outcomes with erlotinib in patients with epidermal growth factor receptor mutationTony S K Mok, Manolo D'arcangelo, Raffaele Califano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Cancer Genomics: Diversity and Disparity Across Ethnicity and GeographyDaniel S W Tan, Tony S K Mok, Timothy R Rebbeck
Annals of Translational Medicine|September 7, 2023
Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative reviewMolly S C Li, Kevin K S Mok, Tony S K Mok
Drugs|May 10, 2019
Dacomitinib in the Management of Advanced Non-Small-Cell Lung CancerSally C M Lau, Ullas Batra, Tony S K Mok, et al.
Pageof 31

Showing results (1-10 of 301) with videos related to

Sort By:
Pageof 31
Nature Reviews. Clinical Oncology|August 25, 2011
Personalized medicine in lung cancer: what we need to knowTony S K Mok
Cancer|August 7, 2009
Maintenance therapy in nonsmall-cell lung cancer: a new treatment paradigmTony S K Mok, Suresh S Ramalingam
Nature Reviews. Clinical Oncology|May 21, 2014
Lung cancer: dropping bars or rising hoops--phase III outcomes of NSCLCHerbert H Loong, Tony S K Mok
Thoracic Surgery Clinics|September 24, 2004
Methodology for quality-of-life assessment: a critical appraisalBenny Chung-Ying Zee, Tony S K Mok
Seminars in Oncology|February 26, 2014
Targeting epidermal growth factor receptor in the management of lung cancerTony S K Mok, Kirsty Lee, Linda Leung
Therapeutic Advances in Medical Oncology|July 4, 2012
Combining chemotherapy with epidermal growth factor receptor inhibition in advanced non-small cell lung cancerLinda Leung, Tony S K Mok, Herbert Loong
Drugs|June 21, 2012
Clinical outcomes with erlotinib in patients with epidermal growth factor receptor mutationTony S K Mok, Manolo D'arcangelo, Raffaele Califano
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2015
Cancer Genomics: Diversity and Disparity Across Ethnicity and GeographyDaniel S W Tan, Tony S K Mok, Timothy R Rebbeck
Annals of Translational Medicine|September 7, 2023
Developments in targeted therapy & immunotherapy-how non-small cell lung cancer management will change in the next decade: a narrative reviewMolly S C Li, Kevin K S Mok, Tony S K Mok
Drugs|May 10, 2019
Dacomitinib in the Management of Advanced Non-Small-Cell Lung CancerSally C M Lau, Ullas Batra, Tony S K Mok, et al.
Pageof 31